IMIDAZOCHINOLINE MIT IMMUNMODULIERENDEN EIGENSCHAFTEN
Patent europeic · EP2155743 · Stritgà
Inscripziun en il register
- Numer da publicaziun
- EP2155743
- Numer da la dumonda
- EP08737252
- Gener
- Patent europeic cun effect per la Svizra ed il Liechtenstein
- Status
- Stritgà
- Scrittira da patent
- Concedì
- Annunzià
- 06-05-2008
- Publitgà
- 24-02-2010
- Concedì
- 29-08-2012
- Stritgà
- 31-05-2019
- Motiv
- Taxa annuala betg pajada
- Classas IPC
- C07D 471/04 (2006.01)A61K 31/437 (2006.01)A61P 37/02 (2006.01)
- Prioritad
- US 916586 P 08.05.2007US 24957 P 31.01.2008
- Dumonda PCT
- PCT/GB2008/050328 06.05.2008
- Publicaziun PCT
- WO2008/135791 13.11.2008
- Lingua da l’annunzia
- englais
- Funtauna
- Swissreg
Istorgia
Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.
- 18-12-2019
Stritgà, taxa betg pajada
Published in Swissreg on 18.12.2019
- 09-11-2016
Transferì
- Owner
- AstraZeneca AB, 151 85 Södertälje, Sweden, Dainippon Sumitomo Pharma Co., Ltd., 6-8, Dosho-machi 2-chome, Chuo-ku, Osaka-shi, Osaka, Japan → SUMITOMO DAINIPPON PHARMA CO., LTD., 6-8, Dosho-machi 2-chome, Chuo-ku, Osaka-shi, Osaka, Japan
Published in Swissreg on 09.11.2016
- 29-08-2012
Concedì
Published in Swissreg on 29.08.2012
Partidas
Inventur
BONNERT, Roger, Victor
Loughborough Leicestershire LE11 5RH, GB
MCINALLY, Thomas
Loughborough Leicestershire LE11 5RH, GB
THOM, Stephen
Loughborough Leicestershire LE11 5RH, GB
WADA, Hiroki
Loughborough, Leicestershire LE11 5RH, GB
Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.